I. Kirby et al., Mutations in the DG loop of adenovirus type 5 fiber knob protein abolish high-affinity binding to its cellular receptor CAR, J VIROLOGY, 73(11), 1999, pp. 9508-9514
The amino acid residues in adenovirus type 5 (Ad5) fiber that interact with
its cellular receptor, the coxsackie PS virus and Ad receptor (CAR), have
not been defined, To investigate this, multiple mutations were constructed
in the region between residues 479 and 497 in Ad5 fiber (beta-strands E and
F and the adjacent region of the DG loop). The effects of these mutations
on binding to CAR were determined by use of cell-binding competition experi
ments, surface plasmon resonance, and direct binding studies. The mutation
effects on the overall folding and secondary structure of the protein were
assessed by circular dichroism (CD) spectroscopy. Deletions of two consecut
ive amino acids between residues 485 and 493 abolished high-affinity bindin
g to CAR; the CD spectra indicated that although there was no disruption of
the overall folding and secondary structure of the protein, local conforma
tional changes did occur. Moreover, single site mutations in this region of
residues with exposed, surface-accessible side chains, such as Thr492, Asn
493, and Val495, had no effect on receptor binding, which demonstrates that
these residues are not in contact with CAR themselves. This implies the in
volvement of residues in neighboring loop regions. Replacement of the segme
nt containing the two very short beta-strands E and F and the turn between
them (residues 479 to 486) with the corresponding sequence from Ad3 (beta E
FAd3 --> 5 mutation) resulted in the loss of receptor binding. The identica
l CD spectra for beta EFAd3 --> 5 and wild-type proteins suggest that these
substitutions caused no conformational rearrangement and that the loss of
binding may thus be due to the substitution of one or more critical contact
residues. These findings have implications for our understanding of the in
teraction of Ad5 fiber with CAR and for the construction of targeted recomb
inant Ad5 vectors for gene therapy purposes.